ACUTE HEREDITARY TYROSINEMIA TYPE-I - CLINICAL, BIOCHEMICAL AND HEMATOLOGICAL STUDIES IN TWINS

被引：16
|
作者：
GRAY, RGF
PATRICK, AD
PRESTON, FE
WHITFIELD, MF
机构：
[1] UNIV SHEFFIELD,SUBDEPT MED GENET,SHEFFIELD S10 5DN,ENGLAND
[2] UNIV LONDON,INST CHILD HLTH,LONDON WC1N 1EH,ENGLAND
[3] CHILDRENS HOSP,DEPT PAEDIAT,SHEFFIELD S10 2TH,S YORKSHIRE,ENGLAND
[4] ROYAL HALLAMSHIRE HOSP,DEPT HAEMATOL,SHEFFIELD S10 2JF,ENGLAND
来源：
JOURNAL OF INHERITED METABOLIC DISEASE | 1981年 / 4卷 / 01期
关键词：
D O I：
10.1007/BF02263580
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：37 / 40
页数：4
相关论文
共 50 条
  • [41] THE EFFECTS OF EARLY TREATMENT OF HEREDITARY TYROSINEMIA TYPE-I IN INFANCY BY ORTHOTOPIC LIVER-TRANSPLANTATION
    FLYE, MW
    RIELY, CA
    HAINLINE, BE
    SASSA, S
    GUSBERG, RJ
    BLAKEMORE, KJ
    BARWICK, KW
    HORWICH, AL
    TRANSPLANTATION, 1990, 49 (05) : 916 - 921
  • [42] PERSISTENT SUCCINYLACETONE EXCRETION AFTER LIVER-TRANSPLANTATION IN A PATIENT WITH HEREDITARY TYROSINEMIA TYPE-I
    TUCHMAN, M
    FREESE, DK
    SHARP, HL
    WHITLEY, CB
    RAMNARAINE, ML
    ULSTROM, RA
    NAJARIAN, JS
    ASCHER, N
    BUIST, NRM
    TERRY, AB
    JOURNAL OF INHERITED METABOLIC DISEASE, 1985, 8 (01) : 21 - 24
  • [43] PRENATAL-DIAGNOSIS OF HEREDITARY TYROSINEMIA TYPE-I BY DETERMINATION OF FUMARYLACETOACETASE IN CHORIONIC VILLUS MATERIAL
    KVITTINGEN, EA
    GUIBAUD, PP
    DIVRY, P
    MANDON, G
    ROLLAND, MO
    DOMENICHINI, Y
    JAKOBS, C
    CHRISTENSEN, E
    EUROPEAN JOURNAL OF PEDIATRICS, 1986, 144 (06) : 597 - 598
  • [44] IDENTIFICATION OF A STOP MUTATION IN 5 FINNISH PATIENTS SUFFERING FROM HEREDITARY TYROSINEMIA TYPE-I
    STLOUIS, M
    LECLERC, B
    LAINE, J
    SALO, MK
    HOLMBERG, C
    TANGUAY, RM
    HUMAN MOLECULAR GENETICS, 1994, 3 (01) : 69 - 72
  • [45] PERIPHERAL-NERVE FINDINGS IN NEUROLOGICAL CRISIS COMPLICATING HEREDITARY HEPATORENAL TYROSINEMIA (TYPE-I)
    MICHAUD, J
    MITCHELL, G
    LAROCHELLE, J
    MELANCON, S
    DALLAIRE, L
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (01) : 97 - 97
  • [46] CLINICAL, BIOCHEMICAL AND ENZYMATIC STUDIES IN TYPE-I HYPERPROLINEMIA ASSOCIATED WITH CHROMOSOMAL ABNORMALITY
    OYANAGI, K
    TSUCHIYAMA, A
    ITAKURA, Y
    TAMURA, Y
    NAKAO, T
    FUJITA, S
    SHIONO, H
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 151 (04): : 465 - 475
  • [47] Different clinical forms of hereditary tyrosinemia (Type I) in patients with identical genotypes
    Poudrier, J
    Lettre, F
    Scriver, CR
    Larochelle, J
    Tanguay, RM
    MOLECULAR GENETICS AND METABOLISM, 1998, 64 (02) : 119 - 125
  • [48] PHARMACOLOGICAL CORRECTION OF NEONATAL LETHAL HEPATIC-DYSFUNCTION IN A MURINE MODEL OF HEREDITARY TYROSINEMIA TYPE-I
    GROMPE, M
    LINDSTEDT, S
    ALDHALIMY, M
    KENNAWAY, NG
    PAPACONSTANTINOU, J
    TORRESRAMOS, CA
    OU, CN
    FINEGOLD, M
    NATURE GENETICS, 1995, 10 (04) : 453 - 460
  • [49] LABORATORY MONITORING OF PATIENTS WITH HEREDITARY TYROSINEMIA TYPE I
    Schultz, Matthew
    Netzel, Brian
    Singh, Rani
    Gavrilov, Dimitar
    Oglesbee, Devin
    Raymond, Kimiyo
    Rinaldo, Piero
    Tortorelli, Silvia
    Matern, Dietrich
    MOLECULAR GENETICS AND METABOLISM, 2019, 126 (03) : 324 - 325
  • [50] TYPE-I HEREDITARY TYROSINEMIA - LACK OF IMMUNOLOGICALLY DETECTABLE FUMARYLACETOACETASE ENZYME PROTEIN IN TISSUES FROM PATIENTS
    BERGER, R
    VANFAASSEN, H
    TAANMAN, JW
    DEVRIES, H
    AGSTERIBBE, E
    PEDIATRIC RESEARCH, 1986, 20 (10) : 1043 - 1043
12345